Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.

NCT: NCT06928337 · COMPLETED

NCT IDNCT06928337
StatusCOMPLETED
Start Date2025-05-01
Completion2026-05-01
SponsorFairtility (INDUSTRY)
First posted
Last updated

Brief Summary

This data collection protocol is aimed to allow the reliable and robust development (training, verification, and validations) of CHLOE technology-based applications as well as improve the machine learning stage of released devices/applications. Additionally, a simulated use assessments will be conducted to ensure the correct and easy use of the CHLOE applications.

Frequently Asked Questions

What is Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.?

Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality. is a clinical trial registered under NCT06928337. Current status: COMPLETED.

What is the status of NCT06928337?

The current status of NCT06928337 (Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.) is: COMPLETED.

When did Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality. start?

Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality. started on 2025-05-01.

Related Devices

K243851CHLOE BLASTFairtility , Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑